{'fraction_non_alphanumeric': 0.023369036027263874, 'fraction_numerical': 0.0, 'mean_word_length': 5.047058823529412, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The abortion ban and mifepristone’s threatening rise

The recent imposition and overrule of the Roe V. Wade abortion law by the US government has created havoc in the state, predicting an alarming rise in mifepristone’s self-usage. This abortion pill is a safer alternative than other methods of abortion which can lead to a rise in its overseas mailing. The potential threat of abuse and unsupervised ingestion of this abortion pill can cause detrimental complications, the emergency treatment of which has been stopped by health care providers. Additionally, the controversial debate on the overlap of post-abortion health care and legal investigations has generated fear among women to receive post-abortion care (PAC), if there is any complication, due to the fright of being prosecuted. This portrays a future threat of an increase in maternal mortality. Although, mifepristone’s use in other diseases is beneficial, instead of banning it, the main focus should be on providing safe post-abortion emergency care if needed.